With a House and Human Services rule in the works to anchor manufacturer drug rebates to pharmacy benefit managers (PBMs) outside the anti-kickback safe harbor, CVS Health is launching its own plan to reduce prescription drug costs and shore up the case for PBM rebates. In a new paper, CVS foghorned the power of PBMs to hold down drug costs, putting the blame for high prescription drug prices on manufacturers.